# Trade Mark Journal No.2026/004 23 January 2026

## UK00004319012 5 January 2026 (5,42)

Mark 1

Mark 2

Mark 3

Class 5
  Medical and veterinary preparations for therapeutic purposes; preparations for cell therapy; preparations for gene therapy; preparations for cancer therapies; preparations for autoimmune diseases; chimeric antigen receptors (CAR) and therapeutic preparations thereof; antibodies; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations; pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of autoimmune diseases; biological preparations for the treatment of cancer; biological preparations for use in the treatment of autoimmune diseases; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; gene therapy.
Class 42
  Scientific and technological services and research and design relating thereto; industrial analysis and research services; research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in the development of autoimmune diseases and new cancer therapies; scientific research in human and animal cell therapy; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells.

Alceus Biosciences Ltd